HSBC Holdings’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $753K | Buy |
+38,017
| New | +$930K | ﹤0.01% | 2007 |
|
|
2025
Q1 | – | Sell |
-8,991
| Closed | -$330K | – | 3024 |
|
|
2024
Q4 | $330K | Buy |
8,991
+1,707
| +23% | +$78.1K | ﹤0.01% | 2441 |
|
|
2024
Q3 | $355K | Buy |
7,284
+566
| +8% | +$24.8K | ﹤0.01% | 2223 |
|
|
2024
Q2 | $271K | Sell |
6,718
-711
| -10% | -$29.5K | ﹤0.01% | 2356 |
|
|
2024
Q1 | $326K | Buy |
+7,429
| New | +$384K | ﹤0.01% | 2395 |
|
|
2023
Q4 | – | Sell |
-7,163
| Closed | -$330K | – | 2714 |
|
|
2023
Q3 | $330K | Buy |
+7,163
| New | +$391K | ﹤0.01% | 2175 |
|
|
2023
Q1 | – | Sell |
-10,370
| Closed | -$289K | – | 2663 |
|
|
2022
Q4 | $289K | Buy |
10,370
+2,277
| +28% | +$66.1K | ﹤0.01% | 2575 |
|
|
2022
Q3 | $232K | Buy |
8,093
+505
| +7% | +$16.5K | ﹤0.01% | 2550 |
|
|
2022
Q2 | $263K | Sell |
7,588
-828
| -10% | -$29.5K | ﹤0.01% | 2708 |
|
|
2022
Q1 | $308K | Buy |
+8,416
| New | +$239K | ﹤0.01% | 2735 |
|
|
2021
Q4 | – | Sell |
-21,718
| Closed | -$420K | – | 3246 |
|
|
2021
Q3 | $420K | Hold |
21,718
| – | – | ﹤0.01% | 2361 |
|
|
2021
Q2 | $435K | Sell |
21,718
-1,215
| -5% | -$22.9K | ﹤0.01% | 2279 |
|
|
2021
Q1 | $420K | Sell |
22,933
-1,380
| -6% | -$25.7K | ﹤0.01% | 2096 |
|
|
2020
Q4 | $485K | Hold |
24,313
| – | – | ﹤0.01% | 2226 |
|
|
2020
Q3 | $460K | Buy |
24,313
+716
| +3% | +$14.4K | ﹤0.01% | 1993 |
|
|
2020
Q2 | $530K | Buy |
23,597
+6,265
| +36% | +$115K | ﹤0.01% | 1802 |
|
|
2020
Q1 | $255K | Buy |
17,332
+4,902
| +39% | +$85.3K | ﹤0.01% | 2150 |
|
|
2019
Q4 | $240K | Sell |
12,430
-16,093
| -56% | -$309K | ﹤0.01% | 2704 |
|
|
2019
Q3 | $566K | Buy |
+28,523
| New | +$594K | ﹤0.01% | 2259 |
|
Other funds holding AMPH
VCM
BTW